Medicine
Ethacrynic acid 25 mg tablet
Ethacrynic acid 25 mg tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in a tightly closed container at 25°C (77°F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Ethacrynic acid
- Brand
- Sold under the generic name
- Strength
- 25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 30 tablets and 11 more
- Manufacturers
- LupinIndiaScieGen PharmaceuticalsSt. Mary's Medical Park PharmacyTruPharmaUpsher-Smith LaboratoriesAmneal Pharmaceuticals NYBryant Ranch PrepackEdenbridge PharmaceuticalsOceanside Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store in a tightly closed container at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03CC01 Ethacrynic acid
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 January 1967
- Identifiers
- RxCUI 1251903, 617325DailyMed set ID de7c25a6-ed00-4ef3-883d-f8841f5dbd02, d400d264-c231-4bdf-8180-eb11ab4e9f29, fd1b7fb4-fe56-4f2d-860d-bbcea16adfea +6NDC 42799-405, 50228-334, 72162-2257 +6Application ANDA205609, ANDA211232, ANDA211719 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 68180-159-01 | LupinIndia | 24 February 2020 |
| 100 tablet in 1 bottle | 69238-1126-1 | Amneal Pharmaceuticals NY | 14 May 2018 |
| 100 tablet in 1 bottle | 42799-405-01 | Edenbridge Pharmaceuticals | 1 July 2016 |
| 100 tablet in 1 bottle | 68682-011-10 | Oceanside Pharmaceuticals | 10 January 1967 |
| 1000 tablet in 1 bottle | 50228-334-01 | ScieGen Pharmaceuticals | 27 August 2019 |
| 100 tablet in 1 bottle | 50228-334-10 | ScieGen Pharmaceuticals | 27 August 2019 |
| 30 tablet in 1 bottle | 50228-334-30 | ScieGen Pharmaceuticals | 27 August 2019 |
| 100 tablet in 1 bottle | 52817-367-10 | Trupharma | 12 September 2019 |
| 90 tablet in 1 bottle | 52817-367-90 | Trupharma | 12 September 2019 |
| 100 tablet in 1 bottle | 0832-1690-11 | Upsher-Smith Laboratories | 19 February 2020 |
| 30 tablet in 1 bottle | 0832-1690-30 | Upsher-Smith Laboratories | 19 February 2020 |
| 100 tablet in 1 bottle | 72162-2257-1 | Bryant Ranch Prepack | 27 August 2019 |
| 30 tablet in 1 bottle, plastic | 60760-773-30 | St. Mary's Medical Park Pharmacy | 9 February 2023 |
| 60 tablet in 1 bottle, plastic | 60760-773-60 | St. Mary's Medical Park Pharmacy | 9 February 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 January 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ethacrynic acid 25 mg tablet.
Clinical summary
Ethacrynic acid is a loop diuretic indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. It is available as tablets for oral use. MedsAcross supplies Ethacrynic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Ethacrynic acidFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ethacrynic acid prescribing information (Oceanside Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Ethacrynic acid 25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.